Jade Biosciences, Inc.
JBIO
$24.71
$0.903.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 48.16% | -7.40% | 69.00% | -9.97% | 342.51% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.10% | -42.95% | 415.60% | 20.23% | 163.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 47.95% | -8.69% | 73.23% | -9.70% | 339.78% |
|
|
|||||
| Total Current Assets | 47.95% | -8.69% | 73.23% | -9.70% | 339.78% |
| Net Property, Plant & Equipment | -6.38% | -5.47% | -2.18% | -0.87% | 20.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -60.34% | 190.00% | -98.76% |
| Total Assets | 47.80% | -8.68% | 72.77% | -9.61% | 297.64% |
|
|
|||||
| Total Accounts Payable | 51.12% | 90.22% | 64.55% | -83.75% | 79.53% |
| Total Accrued Expenses | -2.72% | 8.74% | -10.41% | 53.38% | 6.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 489.92% | 1.57% | 5.83% | 531.58% | -- |
| Total Finance Division Other Current Liabilities | 266.33% | -- | -- | 38.84% | 74.49% |
| Total Other Current Liabilities | 266.33% | -- | -- | 38.84% | 74.49% |
| Total Current Liabilities | 41.62% | 34.78% | -26.02% | 3.41% | 34.71% |
|
|
|||||
| Total Current Liabilities | 41.62% | 34.78% | -26.02% | 3.41% | 34.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.51% | -6.22% | -3.08% | -5.68% | 1.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 40.17% | 33.06% | -25.28% | 3.09% | -83.97% |
|
|
|||||
| Common Stock & APIC | 39.01% | 0.94% | 57.49% | 0.91% | 19,366.54% |
| Retained Earnings | -25.97% | -23.15% | -22.42% | -21.47% | -37.74% |
| Treasury Stock & Other | -92.98% | -365.12% | 344.83% | 220.83% | -- |
| Total Common Equity | 48.39% | -10.84% | 85.40% | -11.02% | 341.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.39% | -10.84% | 85.40% | -11.02% | 341.36% |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.39% | -10.84% | 85.41% | -11.02% | 341.36% |
|
|
|||||